269 related articles for article (PubMed ID: 15325939)
61. Long-term efficacy and safety of a generic atorvastatin in usual clinical care setting.
Ong LM; Punithavathi N; Lena YL; Mahanim O; Leekha S;
Med J Malaysia; 2011 Aug; 66(3):214-9. PubMed ID: 22111443
[TBL] [Abstract][Full Text] [Related]
62. Efficacy and tolerability of a generic and a branded formulation of atorvastatin 20 mg/d in hypercholesterolemic Korean adults at high risk for cardiovascular disease: a multicenter, prospective, randomized, double-blind, double-dummy clinical trial.
Kim SH; Park K; Hong SJ; Cho YS; Sung JD; Moon GW; Yoon MH; Lee MY; Hyon MS; Kim DW; Kim HS
Clin Ther; 2010 Oct; 32(11):1896-905. PubMed ID: 21095484
[TBL] [Abstract][Full Text] [Related]
63. [Lowering cholesterol. New concepts with atorvastatin].
Internist (Berl); 1997 Jan; 38(1 Suppl):1-8. PubMed ID: 9102396
[No Abstract] [Full Text] [Related]
64. Efficacy of alternate-day dosing versus daily dosing of atorvastatin.
Jafari M; Ebrahimi R; Ahmadi-Kashani M; Balian H; Bashir M
J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):123-6. PubMed ID: 12808485
[TBL] [Abstract][Full Text] [Related]
65. Short-term effect of atorvastatin in hypercholesterolaemic renal-transplant patients unresponsive to other statins.
Romero R; Calviño J; Rodriguez J; Sánchez-Guisande D
Nephrol Dial Transplant; 2000 Sep; 15(9):1446-9. PubMed ID: 10978406
[TBL] [Abstract][Full Text] [Related]
66. Pitavastatin and Atorvastatin double-blind randomized comPArative study among hiGh-risk patients, including thOse with Type 2 diabetes mellitus, in Taiwan (PAPAGO-T Study).
Liu PY; Lin LY; Lin HJ; Hsia CH; Hung YR; Yeh HI; Wu TC; Chen JY; Chien KL; Chen JW
PLoS One; 2013; 8(10):e76298. PubMed ID: 24098467
[TBL] [Abstract][Full Text] [Related]
67. Markers of cholesterol absorption and synthesis predict the low-density lipoprotein cholesterol response to atorvastatin.
Hoenig MR; Walker PJ; Gurnsey C; Beadle K; Johnson L
J Cardiovasc Pharmacol; 2010 Oct; 56(4):396-401. PubMed ID: 20625310
[TBL] [Abstract][Full Text] [Related]
68. Short-term effects of periodontal therapy as an adjunct to anti-lipemic treatment.
Fentoğlu O; Sözen T; Oz SG; Kale B; Sönmez Y; Tonguç MO; Gürgan CA; Aykaç Y; Kirzioğlu FY
Oral Dis; 2010 Oct; 16(7):648-54. PubMed ID: 20412449
[TBL] [Abstract][Full Text] [Related]
69. [Atorvastatin].
Kajinami K; Takekoshi N
Nihon Rinsho; 2001 Mar; 59 Suppl 3():598-604. PubMed ID: 11347138
[No Abstract] [Full Text] [Related]
70. Lack of effect of 8 weeks atorvastatin on microvascular endothelial function in patients with systemic sclerosis.
Sadik HY; Moore TL; Vail A; Murray A; Anderson M; Blann A; Herrick AL
Rheumatology (Oxford); 2010 May; 49(5):990-6. PubMed ID: 20159906
[TBL] [Abstract][Full Text] [Related]
71. Assessment of the efficacy and tolerability of 2 formulations of atorvastatin in Korean adults with hypercholesterolemia: a multicenter, prospective, open-label, randomized trial.
Kim SH; Seo MK; Yoon MH; Choi DH; Hong TJ; Kim HS
Clin Ther; 2013 Jan; 35(1):77-86. PubMed ID: 23274145
[TBL] [Abstract][Full Text] [Related]
72. Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine.
Bolayirli IM; Aslan M; Balci H; Altug T; Hacibekiroglu M; Seven A
Life Sci; 2007 Jun; 81(2):121-7. PubMed ID: 17532348
[TBL] [Abstract][Full Text] [Related]
73. Effect of atorvastatin of the treatment of hypercholesterolemia after renal transplantation.
Alvarez ML; Errasti P; Gómez G; Lavilla FJ; García N; Ballester B; García I; Purroy A
Transplant Proc; 1999 Sep; 31(6):2328-9. PubMed ID: 10500602
[No Abstract] [Full Text] [Related]
74. Atorvastatin.
Wierzbicki AS
Expert Opin Pharmacother; 2001 May; 2(5):819-30. PubMed ID: 11336625
[TBL] [Abstract][Full Text] [Related]
75. Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl.
Wassmann S; Ribaudo N; Faul A; Laufs U; Böhm M; Nickenig G
Am J Cardiol; 2004 Jan; 93(1):84-8. PubMed ID: 14697473
[TBL] [Abstract][Full Text] [Related]
76. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.
Bianchi S; Bigazzi R; Caiazza A; Campese VM
Am J Kidney Dis; 2003 Mar; 41(3):565-70. PubMed ID: 12612979
[TBL] [Abstract][Full Text] [Related]
77. Effects of atorvastatin on coagulation parameters and homocysteine in patients with primary hypercholesterolemia.
Bolaman Z; Kadikoylu G; Ozgel N; Yenisey C
J Natl Med Assoc; 2006 Aug; 98(8):1273-7. PubMed ID: 16916124
[TBL] [Abstract][Full Text] [Related]
78. [Aggressive therapy and combination therapy in severe hyperlipidemia].
Kostner KM
Wien Med Wochenschr; 1999; 149(5-6):146-8. PubMed ID: 10408007
[TBL] [Abstract][Full Text] [Related]
79. Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia.
Goldammer A; Wiltschnig S; Heinz G; Jansen M; Stulnig T; Hörl WH; Derfler K
Metabolism; 2002 Aug; 51(8):976-80. PubMed ID: 12145769
[TBL] [Abstract][Full Text] [Related]
80. Updated guidelines support even lower cholesterol levels for at-risk patients.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
